In the Original Investigation titled “Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial,”1 the phrasing of sentences in the Safety section of the Results was corrected, “PP-NRS total score” was changed to “PP-NRS total score, mean (SD)” in Table 1, and 6 superscript letters in Figure 3 were changed from “c” or “d” to “a”. This article was corrected on October 6, 2021.
References
- 1.Eichenfield LF, Flohr C, Sidbury R, et al. Efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis: the JADE TEEN randomized clinical trial. JAMA Dermatol. Published online August 18, 2021. doi: 10.1001/jamadermatol.2021.2830 [DOI] [PMC free article] [PubMed] [Google Scholar]